about
Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysisAssociation between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-AnalysisHorizontal integration of OMIM across the medical school preclinical curriculum for early reinforcement of clinical genetics principlesMyelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activityUse of thiopurines in inflammatory bowel disease: Safety issues.Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment responseAutoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of DiseasePharmacogenetics and immunosuppressive drugs.Pharmacogenetics of drug metabolizing enzymes in the United Kingdom population: review of current knowledge and comparison with selected European populations.Screening and vaccinations in patients requiring systemic immunosuppression: an update for dermatologists.Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro.Systemic lupus erythematosus diagnosis and management.Synthetic pharmacotherapy for lupus nephritis.Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods.Pharmacogenetics of inflammatory bowel disease: a focus on Crohn's disease.Risk factors for thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype.Opportunities and limitations: the value of pharmacogenetics in clinical practice.NUDT15 c.415C>T increases risk of 6-mercaptopurine induced myelosuppression during maintenance therapy in children with acute lymphoblastic leukemia.Pharmacogenetics: a general review on progress to date.Thiopurine S-methyltransferase activity in Nigerians: phenotypes and activity reference values.Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons Learned.Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease.Treatment of MuSK-Associated Myasthenia Gravis.Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?The economic case for precision medicine.Quantification of 6-Mercaptopurine and Its Metabolites in Patients with Acute Lympoblastic Leukemia Using Dried Blood Spots and UPLC-MS/MS.
P2860
Q28544873-4ABEB7A1-4276-44D6-94AC-266A4BB3D4A9Q28551326-D25FDD8F-D9D3-4090-BF68-80BAD3765857Q28603134-CE8F8ED8-D303-49B9-8BEE-1A0867D24107Q33418418-6B16440E-EAED-487C-A5E3-9BB57CCADA4CQ33621267-648BFDD1-4C07-4527-931D-3575FF11711EQ33674158-3EE88939-2E05-4E6D-B4D0-C1595CB29C7DQ35906055-A87BBF09-054F-412A-8E9C-3EEDE2374D39Q38258677-1F15C546-4D51-401B-A205-787F3F141D9CQ38388873-119FD1C8-A5D8-44CC-A41B-C9A954A11CF8Q38411930-E2C07161-7004-4BBD-AB47-473A0EB16F6DQ38881833-37376FA5-EED8-4291-A729-2F105C05E0DCQ39053129-CC0EFBBB-2DFF-4D48-8011-CF7E87946302Q39064602-02B3D29B-164A-40DD-B21A-068C7F7E7715Q39334739-47ACFF69-AAA4-4412-9EA8-8AB4256DAFE6Q39420665-CE8FF9B8-5BA8-41D6-931C-4EF378568F00Q40044141-2752D3AC-5977-42F6-A85F-D8ED3772B048Q42383190-97B32858-8674-4792-9675-15E98250AAB5Q43109007-9BE4703D-E6F7-4E86-8C8A-4CFD78A6402AQ47776901-0B44687B-F4A5-4BF6-820F-E3366BFF7742Q49387116-69DE94CF-349F-49BD-835E-5AFEF3867B2CQ49918608-9FD3A6BB-F4A2-416A-852A-21F01C764491Q51647916-B2C80A88-75EF-4025-8754-473769A49D07Q54379059-95D22D63-1219-49F1-8D87-6097A05E92B7Q55064299-D13D4838-27CE-4590-8D96-06FA8924A8B8Q55217201-04F514E3-BD9A-46EE-9B49-695850C74774Q55383690-4B00B669-8969-4324-B886-E74456F68D5F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Implementation of TPMT testing.
@en
Implementation of TPMT testing.
@nl
type
label
Implementation of TPMT testing.
@en
Implementation of TPMT testing.
@nl
prefLabel
Implementation of TPMT testing.
@en
Implementation of TPMT testing.
@nl
P2860
P356
P1476
Implementation of TPMT testing.
@en
P2093
Lynne Lennard
P2860
P304
P356
10.1111/BCP.12226
P407
P577
2014-04-01T00:00:00Z